Search
Find exactly what you’re looking for.
Search

Section
Topics
Industry
Service
Insights
Series
Location
Showing 141-160 of 214 results

Three states legalized adult recreational marijuana use in 2022 and the use of therapeutic psychedelics is gaining acceptance as two more states this year legalized their use, some cities have decriminalized their use and more states may legalize them in the future. But while use of these drugs may...
​As the cannabis industry continues to grow and expand at a rapid pace, successful operators could become the targets of labeling class actions that have plagued the traditional food and beverage industry for decades, especially in plaintiff-friendly jurisdictions like California. Suits related to...

Cannabis Law Partner Zachary Kobrin in Fort Lauderdale shared with Law.com his 2023 cannabis law predictions, including more consolidation and perhaps more Congressional consternation in the year ahead. Kobrin was quoted: “2023 will be a year of consolidation and reduction for the cannabis industry...

This month’s Friday Five explores recent decisions that illustrate the importance of the administrative record built by a claims administrator, and the impact that the depth and thoroughness of the record will have on litigation over claims decisions. Whether reviewing claims under the de novo...
​As interest in psychedelics rises, amidst the decriminalization of psychedelic substances in various jurisdictions and the regulation of the provision of psilocybin services in Oregon, institutions of higher education may find themselves wondering how to navigate the myriad questions that come...

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In a Cannabis Business Times article, Partner Zachary Kobrin in Fort Lauderdale shared predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift in the next year. On the topic of the SAFE Banking Act, Kobrin said it is “the most...

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

Zachary Kobrin spoke on a panel titled, “Mock Negotiation: Buying/Selling A License” at The Marijuana Business Conference (MJBizCon) Cannabis Law Sessions presented by The International Cannabis Bar Association (INCBA). This panel featured a mock negotiation of the purchase/sale of a cannabis...
For More Information
Contact us